Photodynamic therapy of cancer. Basic principles and applications

[1]  Stanley B. Brown,et al.  Verteporfin: a milestone in opthalmology and photodynamic therapy , 2001, Expert opinion on pharmacotherapy.

[2]  R. M. Szeimiesa,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .

[3]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[4]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[5]  K. Svanberg,et al.  A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. , 2005, Acta dermato-venereologica.

[6]  Á. Villanueva,et al.  Porphycenes: facts and prospects in photodynamic therapy of cancer. , 2007, Current medicinal chemistry.

[7]  Á. Villanueva,et al.  Metaphase arrest and cell death induced by etoposide on HeLa cells. , 2006, The international journal of biochemistry & cell biology.

[8]  Nancy L Oleinick,et al.  The role of apoptosis in response to photodynamic therapy: what, where, why, and how , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[9]  Patrizia Agostinis,et al.  Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. , 2007, Biochimica et biophysica acta.

[10]  Norbert Lange,et al.  Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. , 2004, Advanced drug delivery reviews.

[11]  Á. Villanueva,et al.  Photodamage Induced by Zinc(II)‐phthalocyanine to Microtubules, Actin, α‐Actinin and Keratin of HeLa Cells ¶ , 2001, Photochemistry and photobiology.

[12]  H. Nalwa,et al.  Handbook of Photochemistry and Photobiology , 2003 .

[13]  S. Gibson,et al.  Current clinical and preclinical photosensitizers for use in photodynamic therapy. , 2004, Journal of medicinal chemistry.

[14]  H Anholt,et al.  Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. , 1997, Cancer research.

[15]  K. Berg,et al.  THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.

[16]  S. Horwitz,et al.  Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. , 2001, Molecular pharmacology.

[17]  Joris Kloek,et al.  Prodrugs of 5‐Aminolevullinic Acid for Photodynamic Therapy , 1996, Photochemistry and photobiology.

[18]  B. Pogue,et al.  Liposomal delivery of photosensitising agents , 2005, Expert opinion on drug delivery.

[19]  R. Bissonnette,et al.  Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice , 2005, The British journal of dermatology.

[20]  D. Kessel.  Relocalization of cationic porphyrins during photodynamic therapy , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[21]  D. Kessel,et al.  Initiation of apoptosis and autophagy by photodynamic therapy , 2006, Lasers in surgery and medicine.

[22]  Jörg Schmidbauer,et al.  Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. , 2004, The Journal of urology.

[23]  Qian Peng,et al.  Milestones in the development of photodynamic therapy and fluorescence diagnosis , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[24]  Chryso Kanthou,et al.  Disrupting tumour blood vessels , 2005, Nature Reviews Cancer.

[25]  D. Kessel,et al.  Chemical, biologic and biophysical studies on 'hematoporphyrin derivative'. , 1985, Advances in experimental medicine and biology.

[26]  J. Moan,et al.  Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice , 2002, Archives of Dermatological Research.

[27]  R. Szeimies.  Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma. , 2007, Dermatologic clinics.

[28]  T. Hasan,et al.  Targeted photodynamic therapy , 2006, Lasers in surgery and medicine.

[29]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[30]  C. Gomer,et al.  Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment , 2006, Lasers in surgery and medicine.

[31]  A. Batlle,et al.  Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. , 2002, Current medicinal chemistry. Anti-cancer agents.

[32]  M. Olivo,et al.  ART AND SCIENCE OF PHOTODYNAMIC THERAPY , 2006, Clinical and experimental pharmacology & physiology.

[33]  L. Naldi,et al.  The epidemiology of skin cancer , 2002, The British journal of dermatology.

[34]  Michael Landthaler,et al.  Photodynamic therapy in dermatology. , 2006, European journal of dermatology : EJD.

[35]  M. Esteller,et al.  Loss of E‐cadherin mediated cell–cell adhesion as an early trigger of apoptosis induced by photodynamic treatment , 2005, Journal of cellular physiology.